Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the (a) efficacy of the AstraZeneca covid-19 vaccine on over 65s and (b) implications for his policies of Germany banning the vaccine for its over-65 population.

Current evidence for the AstraZeneca vaccine does not suggest a lack of protection against COVID-19 in people aged 65 years and over. The Department continues to work closely with the Medicines and Healthcare products Regulatory Agency and its international counterparts to assess any new data on the use of all COVID-19 vaccines.